ALK licenses rights to neffy, an adrenaline nasal spray for emergency treatment of anaphylaxis EP News Bureau Nov 12, 2024 ALK also gains rights to future indications, including acute urticaria flares (in development)
MHRA issues anaphylaxis warning for Pfizer BioNTech vaccine Reuters Dec 10, 2020 Pfizer and BioNTech said they were supporting the MHRA’s investigation
